Molecular building blocks and nutrients as a novel cancer treatment

In this invention, a novel cancer drug is formed by Cu(II) and Fe(III) binding the medicinal molecule Paclitaxel (PAC). This complexation increases the water solubility of the taxane, alters the structure so resistance mechanisms do not recognize it, and adds additional toxicity. The copper (II) spe...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas Manning, Teighlor Livingston, Capri Persaud, Akshil Patel, James Nienow
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Invention Disclosure
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772444124000028
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849711425217363968
author Thomas Manning
Teighlor Livingston
Capri Persaud
Akshil Patel
James Nienow
author_facet Thomas Manning
Teighlor Livingston
Capri Persaud
Akshil Patel
James Nienow
author_sort Thomas Manning
collection DOAJ
description In this invention, a novel cancer drug is formed by Cu(II) and Fe(III) binding the medicinal molecule Paclitaxel (PAC). This complexation increases the water solubility of the taxane, alters the structure so resistance mechanisms do not recognize it, and adds additional toxicity. The copper (II) species can generate reactive oxidation species (ROS) and randomly bind and distort proteins within a cancer cell. Cu(II) also plays a role in accelerating angiogenesis and creates a Trojan horse effect that increases its uptake rate by the cancer cells. The empirical formula for the complex is CuxFeyPAC1, where X + Y equals a value between 0 and 10.
format Article
id doaj-art-7f045fe0b41e42aebd924d34ea0b3d3e
institution DOAJ
issn 2772-4441
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Invention Disclosure
spelling doaj-art-7f045fe0b41e42aebd924d34ea0b3d3e2025-08-20T03:14:38ZengElsevierInvention Disclosure2772-44412024-01-01410002110.1016/j.inv.2024.100021Molecular building blocks and nutrients as a novel cancer treatmentThomas Manning0Teighlor Livingston1Capri Persaud2Akshil Patel3James Nienow4Chemistry Department, Valdosta State University, Valdosta, GA 31698, USA; Corresponding author.Philadelphia College of Osteopathic Medicine, Moultrie, GA, USAChemistry Department, Valdosta State University, Valdosta, GA 31698, USAChemistry Department, Valdosta State University, Valdosta, GA 31698, USABiology Department, SEM Lab, Valdosta State University, Valdosta, GA 31698, USAIn this invention, a novel cancer drug is formed by Cu(II) and Fe(III) binding the medicinal molecule Paclitaxel (PAC). This complexation increases the water solubility of the taxane, alters the structure so resistance mechanisms do not recognize it, and adds additional toxicity. The copper (II) species can generate reactive oxidation species (ROS) and randomly bind and distort proteins within a cancer cell. Cu(II) also plays a role in accelerating angiogenesis and creates a Trojan horse effect that increases its uptake rate by the cancer cells. The empirical formula for the complex is CuxFeyPAC1, where X + Y equals a value between 0 and 10.http://www.sciencedirect.com/science/article/pii/S2772444124000028CancerPaclitaxelCopperIronWarburg effect
spellingShingle Thomas Manning
Teighlor Livingston
Capri Persaud
Akshil Patel
James Nienow
Molecular building blocks and nutrients as a novel cancer treatment
Invention Disclosure
Cancer
Paclitaxel
Copper
Iron
Warburg effect
title Molecular building blocks and nutrients as a novel cancer treatment
title_full Molecular building blocks and nutrients as a novel cancer treatment
title_fullStr Molecular building blocks and nutrients as a novel cancer treatment
title_full_unstemmed Molecular building blocks and nutrients as a novel cancer treatment
title_short Molecular building blocks and nutrients as a novel cancer treatment
title_sort molecular building blocks and nutrients as a novel cancer treatment
topic Cancer
Paclitaxel
Copper
Iron
Warburg effect
url http://www.sciencedirect.com/science/article/pii/S2772444124000028
work_keys_str_mv AT thomasmanning molecularbuildingblocksandnutrientsasanovelcancertreatment
AT teighlorlivingston molecularbuildingblocksandnutrientsasanovelcancertreatment
AT capripersaud molecularbuildingblocksandnutrientsasanovelcancertreatment
AT akshilpatel molecularbuildingblocksandnutrientsasanovelcancertreatment
AT jamesnienow molecularbuildingblocksandnutrientsasanovelcancertreatment